Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Bax, J.J.
Right arrow Articles by Poldermans, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bax, J.J.
Right arrow Articles by Poldermans, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Evaluation of patients with chronic ischaemic left ventricular dysfunction - assessment of tissue viability

J.J. Bax*,1, A. Elhendy2, E. Boersma2 and D. Poldermans2

a Leiden University Medical Center, Leiden, The Netherlands
b Thorax Center Rotterdam, The Netherlands

* Correspondence: J.J. Bax, Department of Cardiology, University Hospital Leiden, Rijnsburgerweg 10, 2333 AA Leiden, The Netherlands.

Abstract

There is growing interest in the assessment of myocardial viability in patients with ischaemic left ventricular dysfunction, in an attempt to identify those patients most likely to show functional improvement post-revascularization. Various techniques, focusing on different ‘viability characteristics’, are currently available. Of these, myocardial perfusion imaging (MPI) and dobutamine stress echocardiography are used most often; however, nuclear imaging techniques are more sensitive for the assessment of viable tissue. Revascularization of patients with viable tissue has been shown to improve function, reduce heart failure symptoms, improve exercise capacity and improve survival compared with patients with viable myocardium treated medically. Thus, assessment of viability using MPI may guide optimal management of patients with ischaemic left ventricular dysfunction.

Key Words: Myocardial perfusion imaging • left ventricular dysfunction • tissue viability

References

  1. Gheorghiade M, Bonow RO. Chronic heart failure in the United States. A manifestation of coronary artery disease. Circulation. 1998;97:282–289[Free Full Text]
  2. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987;76:44–51[Abstract/Free Full Text]
  3. Bonow RO. The hibernating myocardium: implications for management of congestive heart failure. Am J Cardiol. 1995;75:17A–25A[CrossRef][Medline]
  4. Beller GA. Assessment of myocardial viability. Curr Opin Cardiol. 1997;12:459–467[Web of Science][Medline]
  5. Bax JJ, Poldermans D, Elhendy A, Boersma E, Rahimtoola SH. Sensitivity, specificity and predictive accuracies of various non-invasive techniques for detecting hibernating myocardium. Curr Probl Cardiol. 2001;26:144–173
  6. Baer FM, Theissen P, Schneider CA, et al. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol. 1998;31:1040–1048[Abstract/Free Full Text]
  7. Everaert H, Vanhove C, Franken PR. Effects of low-dose dobutamine on left ventricular function in normal subjects as assessed by gated single-photon emission tomography myocardial perfusion studies. Eur J Nucl Med. 1999;26:1298–1303[CrossRef][Web of Science][Medline]
  8. Panza JA, Dilsizian V, Laurienzo JM, Curiel RV, Katsiyiannis PT. Relation between thallium uptake and contractile response to dobutamine. Implications regarding myocardial viability in patients with chronic coronary artery disease and left ventricular dysfunction. Circulation. 1995;91:990–998[Abstract/Free Full Text]
  9. Cornel JH, Bax JJ, Elhendy A, et al. Agreement and disagreement between ‘metabolic viability’ and ‘contractile reserve’ in a kinetic myocardium. J Nucl Cardiol. 1999;6:383–388[CrossRef][Web of Science][Medline]
  10. Pagano D, Townend IN, Parums DV, Bonser RS, Camici PG. Hibernating myocardium: morphological correlates of isotropic stimulation and glucose uptake. Heart. 2000;83:456–461[Abstract/Free Full Text]
  11. Bax JJ, Poldermans D, Visser FC, et al. Delayed recovery of hibernating myocardium after surgical revascularization: implications for discrepancy between metabolic imaging and dobutamine echocardiography for assessment of myocardial viability. J Nucl Cardiol. 1999;6:685–687[CrossRef][Web of Science][Medline]
  12. Sciagra R, Bisi G, Santoro GM, et al. Comparison of baselinenitrate technetium-99m sestamibi with rest-redistribution thallium-201 tomography in detecting viable hibernating myo cardium and predicting postrevascularization recovery. J Am Coll Cardiol. 1997;30:384–391[Abstract]
  13. Vom Dahl J, Altehoefer C, Sheehan FH, et al. Recovery of regional left ventricular dysfunction after coronary revascularization. Impact of myocardial viability assessed by nuclear imaging and vessel patency at follow-up angiography. J Am Coll Cardiol. 1996;28:948–958[Abstract]
  14. Ragosta M, Beller GA, Watson DD, Kaul S, Gimple LW. Quantitative planar rest-redistribution 201T1 imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation. 1993;87:1630–1641[Abstract/Free Full Text]
  15. Lombardo A, Loperfido F, Trani C, et al. Contractile reserve of dysfunctional myocardium after revascularization: a dobutamine stress echocardiography study. J Am Coll Cardiol. 1997;30:633–640[Abstract]
  16. Bax JJ, Poldermans D, Visser FC, et al. Relation between preoperative viability and postoperative improvement of LVEF and heart failure symptoms. J Nucl Med. 2001;42:79–86[Abstract/Free Full Text]
  17. Eitzman D, al-Aouar ZR, Kanter HL, et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol. 1992;20:559–565[Abstract]
  18. Di Carli M, Davidson M, Little R, et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol. 1994;73:527–533[CrossRef][Web of Science][Medline]
  19. DiCarli ME, Asgarzadie F, Schelbert HR, et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation. 1995;92:3436–3444[Abstract/Free Full Text]
  20. Bax JJ, Poldermans D, Elhendy A, et al. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol. 1999;34:163–169[Abstract/Free Full Text]
  21. Pasquet A, Robert A, D'Hondt AM, Dion R, Melin JA, Vanoverschelde JL. Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction. Circulation. 1999;100:141–148[Abstract/Free Full Text]
  22. Pagley PR, Beller GA, Watson DD, Gimple LW, Ragosta M. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation. 1997;96:793–800[Abstract/Free Full Text]
  23. Cuocolo A, Petretta M, Nicolai E, et al. Successful coronary revascularization improves prognosis in patients with previous myocardial infarction and evidence of viable myocardium at thallium-201 imaging. Eur J Nucl Med. 1998;25:60–68[CrossRef][Web of Science][Medline]
  24. Gioia G, Powers J, Heo J, Iskandrian AS. Prognostic value of rest-redistribution tomography thallium-201 imaging in ischemic cardiomyopathy. Am J Cardiol. 1995;75:759–762[CrossRef][Web of Science][Medline]
  25. Bax JJ, Wijns W. Fluorodeoxyglucose imaging to assess myocardial viability: PET, SPECT or gamma camera coincidence imaging? J Nucl Med. 1999;40:1893–1895[Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Bax, J.J.
Right arrow Articles by Poldermans, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bax, J.J.
Right arrow Articles by Poldermans, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?